Should I look into GLP-1s
Rabbit models of osteoarthritis have been examined, with observations pointing to potential changes in joint mobility and cartilage condition
After initiation and dose increases, patients should be observed carefully for signs and symptoms of pancreatitis (including persistent severe abdominal pain, sometimes radiating to the back and which may or may not be accompanied by vomiting)
PROVEN CKD RISK REDUCTION 1,2 Ozempic injection : For adults with T2D and CKD, to reduce the risk of sustained eGFR decline, end-stage kidney disease, and CV death
Endocrinologists or weight loss clinics : These specialists often have more experience with GLP-1 medications and can provide tailored plans
Combination therapy was associated with a lower risk of primary composite outcomes of all-cause hospitalization, all-cause mortality, major adverse cardiovascular events (MACE), major adverse kidney events (MAKE), and major adverse liver outcomes (MALO) (hazard ratio [HR], 0.87